Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Liver Cancer
Clinical trial register · China

Liver Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 09 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 8 Guangzhou 7 Chengdu 6 Shanghai 5 Hefei 3
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing8 Guangzhou7 Chengdu6 Shanghai5 Hefei3
All 31 locations
Target enrolment
to

Liver Cancer trials in China

37 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies
NCT07763301Liver Cancer, Pancreatic Cancer, Biliary Tract Cancer (BTC)
West China Hospital
Phase 1
9
Chengdu
2026-08-01
Recruiting
China Metastatic Liver Cancer Clinical Registry Cohort Database
NCT07602504Liver Metastases, Metastases to Liver, Liver Cancer, Neoplasms
Anhui Provincial Hospital
Observational
2,000
Bengbu, Hefei, Qingdao
2026-06-01
Active, closed
Harbin Medical University
Observational
1,000
Harbin
2026-05-13
Recruiting
West China Hospital
Observational
200
Beijing, Xuzhou, Chengdu
2026-03-01
Recruiting
West China Hospital
Observational
20
Chengdu
2026-01-01
Recruiting
Tongji Hospital
Observational
651
Wuhan
2025-12-20
Active, closed
AI Multimodal Model for Liver Cancer Diagnosis and Prognosis
NCT07658586Liver Cancer, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma (Icc)
Guangxi Medical University
Observational
600
Nanning
2025-12-01
Recruiting
West China Hospital
Phase 1
9
Chengdu
2025-10-23
By invitation
Fudan University
Not applicable
92
Shanghai
2025-10-08
Active, closed
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 1
50
Nanjing
2025-07-01
Recruiting
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
NCT07053488Liver Diseases, Liver Cancer, Liver Cirrhosis, Liver Failure
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Phase 1/2
90
Beijing
2025-06-01
Not yet open
Yunnan Cancer Hospital
Not applicable
150
Kunming
2025-06-01
Recruiting
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
NCT06950814Sarcomatoid Carcinoma, Liver Cancer, Adjuvant Therapy
West China Hospital
Observational
50
Chengdu
2025-04-05
Recruiting
Qurgen Inc.
Phase 1
96
Beijing, Lanzhou, Guangzhou, Nanjing, Xi'an, Jinan, Shanghai, Hangzhou
2025-02-26
Recruiting
Anhui Provincial Hospital
Observational
10,000
Anqing, Bengbu, Bozhou, Chizhou, Chuzhou, Fuyang, Hefei, Huaibei
2025-01-01
Recruiting
TACE Combined Surgery for the Resectable Huge HCC
NCT06898398Hepatocellular Carcinoma, Hepatic Chemotherapy, Liver Cancer, Surgery
Sun Yat-sen University
Observational
326
Beijing
2025-01-01
Not yet open
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2
62
Guangzhou
2025-01-01
Not yet open
Beijing Tsinghua Chang Gung Hospital
Phase 2
46
Beijing
2024-10-20
Recruiting
RenJi Hospital
Phase 4
40
Shanghai
2024-10-16
Recruiting
AI-Assisted Non-Contrast CT for Multi-Cancer Screening
NCT06632886Lung Cancers, Liver Cancer, Gastric Cancers, Colorectal, Cancer
Guo ShiWei
Not applicable
1,000,000
Shanghai
2024-10-07
Recruiting
HAIC Compared With TACE in Huge Hepatocellular Carcinoma
NCT06641713Hepatocellular Carcinoma, Hepatic Chemotherapy, Liver Cancer
Sun Yat-sen University
Observational
664
Beijing
2024-10-01
Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
150
Wuhan
2024-08
Recruiting
JIANGSU SHENMING Medical Technology CO., Ltd
Not applicable
216
Hefei, Beijing, Nanning, Guiyang, Shijiazhuang, Anyang, Luoyang, Zhengzhou
2024-07-29
Recruiting
Second Affiliated Hospital of Guangzhou Medical University
Phase 2
90
Guangzhou
2024-06-10
Recruiting
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
NCT06196294Pancreas Cancer, Lung Cancer, Liver Cancer, Mesothelioma
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
30
Guangzhou
2024-05-10
Recruiting
West China Hospital
Not applicable
524
Chengdu
2024-05-06
Recruiting
Interventional Software for Multi-immunotherapy of Solid Tumors
NCT06478108Lung Cancer, Liver Cancer, Solid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3
60
Guangzhou
2024-04-01
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
9
Shanghai
2024-01-26
Not yet open
Effects of CBT-Based Intervention Among Patients With Liver Cancer
NCT05942560Depression, Anxiety, Liver Cancer, CBT
The Nethersole School of Nursing
Not applicable
160
Zhuhai
2023-12-30
Recruiting
Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
NCT06139042Liver Cancer, Biliary Tract Cancer, Pancreatic Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
1,608
Hangzhou
2023-11-01
Recruiting
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
NCT05444478Hepatocellular Carcinoma, Microwave Ablation, Liver Cancer, Lenvatinib
Sun Yat-sen University
Not applicable
274
Changsha
2022-07-01
Recruiting
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
NCT05187338Lung Cancer, Liver Cancer, Colorectal Cancer, Pancreas Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 1/2
100
Guangzhou
2021-11-01
Recruiting
Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
NCT04842812Liver Cancer, Lung Cancer, Breast Cancer, Colo-rectal Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
40
Guangzhou
2021-01-01
Recruiting
Effect and Mechanism of ALPPS Operation on Liver Regeneration
NCT07142213Hepato Cellular Carcinoma (HCC), Hepatobiliary Cancers, Liver Cancer, Liver Regeneration
Haitao Zhao, MD
Observational
50
Beijing
2020-01-01
Recruiting
Second Affiliated Hospital of Guangzhou Medical University
Phase 3
200
Guanzhou
2019-01-01
Rows per page Showing 1–37 of 37
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/condition/liver-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 09 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 37 of those studies listing the condition Liver Cancer.

How many Liver Cancer trials are recruiting in China?

28 of the 37 studies on this page are recruiting new participants as of the 09 Nov 2026, 03:17 UTC sync. A further 5 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Liver Cancer), 37 studies
PhaseStudiesRecruitingShare
Observational131135.1%
Not applicable8521.6%
Phase 17618.9%
Phase 1/2328.1%
Phase 2215.4%
Phase 4215.4%
Phase 2/3112.7%
Phase 3112.7%

Most active sponsors

Lead sponsors with the most studies (Liver Cancer)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital of Guangzhou Medical University66
West China Hospital66
Sun Yat-sen University33
Anhui Provincial Hospital22
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC11
Beijing Tsinghua Chang Gung Hospital10
Fudan University10
Guangxi Medical University10
Guo ShiWei11
Haitao Zhao, MD11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.